Today marks the one-year anniversary of a unique moment in our country’s health care history. Unfortunately, it is not a celebration: 365 days ago, people living with early Alzheimer’s became the only Americans to be denied access to FDA-approved treatments, thanks to an unprecedented decision made by the Centers for Medicare & Medicaid Services (CMS). One year later, here are 5 important things to know about the impact of this decision and why CMS must immediately reverse it:
1
This is the 1st time in history that Medicare has refused to cover a drug that has been given FDA approval.
2
Each day CMS denies access to FDA-approved Alzheimer’s treatments,
more than 2,000 people transition out of eligibility.
3
In the last 365 days,
more than 730,000 Americans have been denied access to FDA-approved treatments…and as a result, they have also been denied more time with their loved ones.
4
More than 100 bipartisan members of Congress have actively called on CMS to reverse their decision.
5
People living with Alzheimer’s currently have a
0% survival rate. Now that we have medical breakthroughs, the least we can do is offer those living with Alzheimer’s, a fatal disease, #MoreTime.
Join with the Alzheimer’s Association. Use your voice to change this unjust action — click here.